Quarterly Result13 Aug 2026, 09:12 pm
Kilitch Drugs Declares Unaudited Q1 FY27 Results
AI Summary
Kilitch Drugs India Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved both standalone and consolidated results. The company reported total income and incurred expenses, leading to profit before tax. The results were accompanied by a limited review report from the auditors. The board meeting where these results were approved commenced at 16:30 hours and concluded at 20:40 hours on August 13, 2026.
Key Highlights
- Unaudited standalone and consolidated financial results declared.
- Results for the quarter ended June 30, 2026, were approved.
- Board meeting held on August 13, 2026, approved the results.
- Limited Review Report by Auditors is enclosed.
- Company operates predominantly in the Pharmaceuticals business.
Price Impact
More from KILITCH